Supernus Pharmaceuticals
MD - Rockville
PharmaceuticalFocus: Small Molecules
Supernus Pharmaceuticals is a life sciences company focused on Small Molecules.
Neurology
Open Jobs
0
Products & Portfolio (4)
1 discontinued product not shown
GOCOVRI
amantadine
Peak
ORAL · CAPSULE, EXTENDED RELEASE
M2 Protein Inhibitors
2017
0
OXTELLAR XR
oxcarbazepine
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
10-monohydroxy metabolite (MHD) of oxcarbazepine [see ]. The precise mechanism by which oxcarbazepine and MHD exert their antiseizure effect is unknown; however, in vitro electrophysiological studies indicate that they produce blockade of voltage-sensitive sodium channels, resulting in stabilization of hyperexcited neural membranes, inhibition of repetitive neuronal firing, and diminution of propagation of synaptic impulses. These actions are thought to be important in the prevention of seizure spread in the intact brain. In addition, increased potassium conductance and modulation of high-voltage activated calcium channels may contribute to the anticonvulsant effects of the drug. No significant interactions of oxcarbazepine or MHD with brain neurotransmitter or modulator receptor sites have been demonstrated.
partial-onset seizures in patients 6 years of ageolder
2012
15
QELBREE
viloxazine hydrochloride
Peak
ORAL · CAPSULE, EXTENDED RELEASE
2021
0
TROKENDI XR
topiramate
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
Cytochrome P450 3A4 Inducers
2013
15
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 approved products
Top TAs: Infectious Diseases, Neurology
Portfolio Health
Peak3 (60%)
LOE Approaching2 (40%)
5 total products